Evidence map›Paper›PMID 21764858›Full record

Trial reportCancer prevention research (Philadelphia, Pa.)2011

Effect of low-fat diets on plasma levels of NF-κB-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer.

John V Heymach, Terry J Shackleford, Hai T Tran, Suk-Young Yoo, Kim-Anh Do, Melanie Wergin, Pierre Saintigny, Robin T Vollmer, Thomas J Polascik, Denise C Snyder and 6 more

Registry-linked trialOpen access · bronzeAbstract readClinical Trial, Phase IIRandomized Controlled Trial
In one paragraph

Trial report in Cancer prevention research (Philadelphia, Pa.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00049309 (Prostate Cancer), which is not on this map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00049309 phase2completednot on this map

Prostate Cancer: Impact Of Fat And Flaxseed - Modified Diets

TypeinterventionalSponsorDuke UniversityRan2003 to 2006Enrolled161ConditionsProstate CancerArmsdietary intervention, flaxseed
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Review
  10. Review
  11. Review
  12. Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer.International journal of molecular sciences · 2022
    Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Neoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue Resident Memory T Cell, and B Cell Infiltration in Resectable NSCLC.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2021
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

John V HeymachDepartment of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA. jheymach@mdanderson.org
Terry J Shackleford
Hai T Tran
Suk-Young Yoo
Kim-Anh Do
Melanie Wergin
Pierre Saintigny
Robin T Vollmer
Thomas J Polascik
Denise C Snyder
Mack T Ruffin
Shaoyu Yan
Mark Dewhirst
Ajaikumar B Kunnumakkara
Bharat B Aggarwal
Wendy Demark-Wahnefried
Duke Medical Center · USThe University of Texas MD Anderson Cancer Center · USDuke University · USDurham VA Medical Center · USUniversity of Alabama at Birmingham · USUniversity of Michigan–Ann Arbor · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
XOMAZYME-CD5 PLUS THERAPY IN RHEUMATOID ARTHRITISM01RR000030 · NCRR · DUKE UNIVERSITY · PI WILLIAMS, R SANDERS · 1985 to 2006
$20.0M
University of Texas SPORE in Prostate CancerP50CA090270 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LOGOTHETIS, CHRISTOPHER J. · 2001 to 2007
$13.6M
Prostate Cancer: Impact of Fat &Flaxseed Modified DietR01CA085740 · NCI · DUKE UNIVERSITY · PI DEMARK-WAHNEFRIED, WENDY · 2002 to 2005
$1.2M
NCI NIH HHS CA07464830NCI NIH HHS CA16672NCI NIH HHS CA85740NCI NIH HHS CA90270NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA090270NCI NIH HHS R01 CA085740NCRR NIH HHS M01 RR000030NCRR NIH HHS M01-RR-30
6 · The paper itself

Abstract

Diet, nutritional status, and certain dietary supplements are postulated to influence the development and progression of prostate cancer. Angiogenesis and inflammation are central to tumor growth and progression, but the effect of diet on these processes remains uncertain. We explored changes in 50 plasma cytokines and angiogenic factors (CAF) in 145 men with prostate cancer enrolled in a preoperative, randomized controlled phase II trial with four arms: control (usual diet), low-fat (LF) diet, flaxseed-supplemented (FS) diet, and FS+LS diet. The mean duration of dietary intervention was 30 to 31 days. Among the individual arms, the largest number of significant changes (baseline vs. preoperative follow-up) was observed in the LF arm, with 19 CAFs decreasing and one increasing (P < 0.05). Compared with the control arm, 6 CAFs-including proangiogenic factors (stromal-cell derived-1α) and myeloid factors (granulocyte-colony-stimulating factor, macrophage colony-stimulating factor)-all decreased in the LF arm compared with controls; three and four CAFs changed in the FS and FS+LF arms, respectively. Weight loss occurred in the LF arms and significantly correlated with VEGF decreases (P < 0.001). The CAFs that changed in the LF arm are all known to be regulated by NF-κB, and a pathway analysis identified NF-κB as the most likely regulatory network associated with these changes in the LF arm but not in the FS-containing arms. These results suggest that a LF diet without flaxseed may reduce levels of specific inflammatory CAFs and suggests that the NF-κB pathway may be a mediator of these changes.

Indexed as

Diet, Fat-RestrictedAgedAngiogenesis Inducing AgentsBiomarkers, TumorCytokinesDietary SupplementsFlaxFollow-Up StudiesHumansImmunoenzyme TechniquesInflammation MediatorsMaleNF-kappa BPrognosisProstatic NeoplasmsWeight LossAngiogenesis Inducing AgentsBiomarkers, TumorCytokinesInflammation MediatorsNF-kappa B

Identifiers

PMID21764858
PMCPMC3438697
OpenAlexW2153826097

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.